BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 19302801)

  • 1. Differential behavioral and neurochemical effects of exercise, reboxetine and citalopram with the forced swim test.
    Arunrut T; Alejandre H; Chen M; Cha J; Russo-Neustadt A
    Life Sci; 2009 Apr; 84(17-18):584-9. PubMed ID: 19302801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hippocampal brain-derived neurotrophic factor expression following treatment with reboxetine, citalopram, and physical exercise.
    Russo-Neustadt AA; Alejandre H; Garcia C; Ivy AS; Chen MJ
    Neuropsychopharmacology; 2004 Dec; 29(12):2189-99. PubMed ID: 15199375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of reboxetine and citalopram pretreatment on changes in cocaine and amphetamine regulated transcript (CART) expression in rat brain induced by the forced swimming test.
    Kang S; Kim HJ; Kim HJ; Shin SK; Choi SH; Lee MS; Shin KH
    Eur J Pharmacol; 2010 Nov; 647(1-3):110-6. PubMed ID: 20826136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical activity-antidepressant treatment combination: impact on brain-derived neurotrophic factor and behavior in an animal model.
    Russo-Neustadt A; Ha T; Ramirez R; Kesslak JP
    Behav Brain Res; 2001 Apr; 120(1):87-95. PubMed ID: 11173088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Housing conditions modulate escitalopram effects on antidepressive-like behaviour and brain neurochemistry.
    Bjørnebekk A; Mathé AA; Gruber SH; Brené S
    Int J Neuropsychopharmacol; 2008 Dec; 11(8):1135-47. PubMed ID: 18570703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical doses of citalopram or reboxetine differentially modulate passive and active behaviors of female Wistar rats with high or low immobility time in the forced swimming test.
    Flores-Serrano AG; Vila-Luna ML; Álvarez-Cervera FJ; Heredia-López FJ; Góngora-Alfaro JL; Pineda JC
    Pharmacol Biochem Behav; 2013 Sep; 110():89-97. PubMed ID: 23769836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment.
    Cryan JF; Page ME; Lucki I
    Psychopharmacology (Berl); 2005 Nov; 182(3):335-44. PubMed ID: 16001105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous analyses of the neurochemical and behavioral effects of the norepinephrine reuptake inhibitor reboxetine in a rat model of antidepressant action.
    Page ME; Brown K; Lucki I
    Psychopharmacology (Berl); 2003 Jan; 165(2):194-201. PubMed ID: 12426668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noradrenergic lesions differentially alter the antidepressant-like effects of reboxetine in a modified forced swim test.
    Cryan JF; Page ME; Lucki I
    Eur J Pharmacol; 2002 Feb; 436(3):197-205. PubMed ID: 11858799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic neurochemical and behavioural effects of acute intrahippocampal injection of brain-derived neurotrophic factor and antidepressants in adult mice.
    Deltheil T; Tanaka K; Reperant C; Hen R; David DJ; Gardier AM
    Int J Neuropsychopharmacol; 2009 Aug; 12(7):905-15. PubMed ID: 19236729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subtype-selective nicotinic acetylcholine receptor agonists enhance the responsiveness to citalopram and reboxetine in the mouse forced swim test.
    Andreasen JT; Nielsen EØ; Christensen JK; Olsen GM; Peters D; Mirza NR; Redrobe JP
    J Psychopharmacol; 2011 Oct; 25(10):1347-56. PubMed ID: 20360159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of escitalopram, R-citalopram, and reboxetine on serum levels of tumor necrosis factor-α, interleukin-10, and depression-like behavior in mice after lipopolysaccharide administration.
    Dong C; Zhang JC; Yao W; Ren Q; Yang C; Ma M; Han M; Saito R; Hashimoto K
    Pharmacol Biochem Behav; 2016 May; 144():7-12. PubMed ID: 26892759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reboxetine attenuates forced swim test-induced behavioural and neurochemical alterations in the rat.
    Connor TJ; Kelliher P; Harkin A; Kelly JP; Leonard BE
    Eur J Pharmacol; 1999 Aug; 379(2-3):125-33. PubMed ID: 10497898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Citalopram decreases tryptophan 2,3-dioxygenase activity and brain 5-HT turnover in swim stressed rats.
    Ara I; Bano S
    Pharmacol Rep; 2012; 64(3):558-66. PubMed ID: 22814009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotine, but not mecamylamine, enhances antidepressant-like effects of citalopram and reboxetine in the mouse forced swim and tail suspension tests.
    Andreasen JT; Redrobe JP
    Behav Brain Res; 2009 Jan; 197(1):150-6. PubMed ID: 18786574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noradrenergic antidepressants increase cortical dopamine: potential use in augmentation strategies.
    Masana M; Castañé A; Santana N; Bortolozzi A; Artigas F
    Neuropharmacology; 2012 Sep; 63(4):675-84. PubMed ID: 22652058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Voluntary exercise produces antidepressant and anxiolytic behavioral effects in mice.
    Duman CH; Schlesinger L; Russell DS; Duman RS
    Brain Res; 2008 Mar; 1199():148-58. PubMed ID: 18267317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidepressant properties of the 5-HT4 receptor partial agonist, SL65.0155: behavioral and neurochemical studies in rats.
    Tamburella A; Micale V; Navarria A; Drago F
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1205-10. PubMed ID: 19596038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic administration of the delta opioid receptor agonist (+)BW373U86 and antidepressants on behavior in the forced swim test and BDNF mRNA expression in rats.
    Torregrossa MM; Folk JE; Rice KC; Watson SJ; Woods JH
    Psychopharmacology (Berl); 2005 Nov; 183(1):31-40. PubMed ID: 16220339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.
    Deltheil T; Guiard BP; Cerdan J; David DJ; Tanaka KF; Repérant C; Guilloux JP; Coudoré F; Hen R; Gardier AM
    Neuropharmacology; 2008 Nov; 55(6):1006-14. PubMed ID: 18761360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.